Inflammatory myopathy associated with imatinib mesylate therapy

Journal of Clinical Neuromuscular Disease

Volumn 5, Issue 3, 2004, Pages 119-121

  Srinivasan, Jayashri ^a,b   Wu, Catherine J ^c   Amato, Anthony A ^d  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chronic myelogenous leukemia; Human exosome; Imatinib mesylate; Myositis inflammatory myopathy

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIBODY; CREATINE KINASE; CROSS REACTING ANTIGEN; HYDROXYUREA; IMATINIB; LEUKEMIA ANTIGEN; MUSCLE ANTIGEN; PREDNISONE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BICEPS BRACHII MUSCLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CROSS REACTION; DOSE RESPONSE; DRUG MECHANISM; DRUG SURVEILLANCE PROGRAM; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LEUKEMIA CELL; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; PHILADELPHIA 1 CHROMOSOME; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 4644222843     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200403000-00002     Document Type: Article

References (8)

1. Druker BJ, Talpaz M, Resta D, et al. Efficacy and safety of specific inhibitor of the BCR/ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031-1037.
2. Savage DG, Antman KH. Drug therapy: imatinib mesylate - a new oral targeted therapy. N Engl J Med. 2002;346:683-693.
3. Yang X-F, Wu CJ, Chen L, et al. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. Cancer Res. 2002;62:5517-5522.
4. Falcone A, Bodenizza CA, Musto P, et al. Symptomatic myopathy during interferon alpha therapy for chronic myelogenous leukemia. Leukemia. 1998; 12:1329.
5. Lima M, Coutinho J, Bernardo L, et al. Philadelphia-positive T-cell acute lymphoblastic leukemia with polymyositis, migratory polyarthritis and hypercalcemia following chronic myeloid leukemia. Ann Hematol. 2002;81:174-177.
6. Mayeno AN, Belongia EA, Lin F, et al. 3-(phenyl-amino) alanine- a novel aniline-derived aminoacid associated with the eosinophilic-myalgia syndrome: A link to the toxic oil syndrome. Mayo Clin Proc. 1992;67:1134.
7. Amato AA, Dumitru D. Acquired myopathies. In: Dumitru D, Amato AA, Swartz MJ, eds. Electrodiagnostic Medicine, 2nd ed. Philadelphia: Hanley & Belfus, Inc; 2002:1411-1412.
8. Brouwer R, Vree Egberts WTM, Henstan GJD, et al. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res. 2002;4:134-138.